The prognostic significance of lymph node metastasis in pediatric melanoma and atypical melanocytic proliferations

References

• Wong SL, Balch CM, Hurley P et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann. Surg. Oncol. 19(11), 3313–3324 (2012).
   PubMed Web of Science ®Google Scholar
• Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J. Clin. Oncol. 25(11), 1363–1368 (2007).
   PubMed Web of Science ®Google Scholar
• Livestro DP, Kaine EM, Michaelson JS et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer 110(3), 614–624 (2007).
   PubMed Web of Science ®Google Scholar
• Paradela S, Fonseca E, Prieto VG. Melanoma in children. Arch. Pathol. Lab. Med. 135(3), 307–316 (2011).
   PubMed Web of Science ®Google Scholar
• Han D, Zager JS, Han G et al. The unique clinical characteristics of melanoma diagnosed in children. Ann. Surg. Oncol. 19(12), 3888–3895 (2012).
   PubMed Web of Science ®Google Scholar
• Howman-Giles R, Shaw HM, Scolyer RA et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann. Surg. Oncol. 17(1), 138–143 (2010).
   PubMed Web of Science ®Google Scholar
• Moore-Olufemi S, Herzog C, Warneke C et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann. Surg. 253(6), 1211–1215 (2011).
   PubMed Web of Science ®Google Scholar
• Pappo AS. Melanoma in children and adolescents. Eur. J. Cancer 39(18), 2651–2661 (2003).
   PubMed Web of Science ®Google Scholar
• Paradela S, Fonseca E, Pita-Fernández S et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients. Cancer 116(18), 4334–4344 (2010).
   PubMed Web of Science ®Google Scholar
• Mu E, Lange JR, Strouse JJ. Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer 118(10), 2700–2707 (2012).
   PubMed Web of Science ®Google Scholar
• Ludgate MW, Fullen DR, Lee J et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 115(3), 631–641 (2009).
   PubMed Web of Science ®Google Scholar
• Berk DR, Lind AC, Bayliss SJ. Acral angiokeratomas in a patient with Turner syndrome. Pediatr. Dermatol. 27(6), 662–664 (2010).
   PubMed Web of Science ®Google Scholar
• Mills OL, Marzban S, Zager JS, Sondak VK, Messina JL. Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients. J. Cutan. Pathol. 39(3), 331–336 (2012).
   PubMed Web of Science ®Google Scholar
• Raskin L, Ludgate M, Iyer RK et al. Copy number variations and clinical outcome in atypical spitz tumors. Am. J. Surg. Pathol. 35(2), 243–252 (2011).
   PubMed Web of Science ®Google Scholar
• Abraham RM, Ming ME, Elder DE, Xu X. An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J. Cutan. Pathol. 39(1), 21–24 (2012).
   PubMed Web of Science ®Google Scholar
• Cerrato F, Wallins JS, Webb ML, McCarty ER, Schmidt BA, Labow BI. Outcomes in pediatric atypical spitz tumors treated without sentinel lymph node biopsy. Pediatr. Dermatol. 29(4), 448–453 (2012).
   PubMed Web of Science ®Google Scholar
• Aldrink JH, Selim MA, Diesen DL et al. Pediatric melanoma: a single-institution experience of 150 patients. J. Pediatr. Surg. 44(8), 1514–1521 (2009).
   PubMed Web of Science ®Google Scholar
• Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J. Natl Cancer Inst. 102(7), 493–501 (2010).
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Suciu S, Testori A et al. Long-term results of the randomized Phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J. Clin. Oncol. 30(31), 3810–3818 (2012).
   PubMed Web of Science ®Google Scholar
• Navid F, Furman WL, Fleming M et al. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer 103(4), 780–787 (2005).
   PubMed Web of Science ®Google Scholar